APO Research
Talk to an analyst

APO RESEARCH · REPORT

Atropine Sulfate Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Atropine Sulfate Injection Market Analysis and Forecast 2026-2032

21 December 2025205 pages

Choose your research edition.

Industry ResearchAtropine Sulfate Injection Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Atropine Sulfate Injection Industry Growth and Trends Forecast to 2032125 pages · $3,450 USDMarket StructureGlobal Atropine Sulfate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Atropine Sulfate Injection Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Atropine Sulfate Injection Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Atropine Sulfate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Atropine Sulfate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Atropine Sulfate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Atropine Sulfate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Atropine Sulfate Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Atropine Sulfate Injection include Tianjin Jinyao Pharmaceutical, Tai Yu Chemical & Pharmaceutical, Suicheng Pharmaceutical, CSPC Ouyi Pharmaceutical, China Shineway Pharm, Shanghai Harvest Pharmaceutical, Sunflower Pharmaceutical, Pfizer and China Res Double-Crane, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Atropine Sulfate Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Atropine Sulfate Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Atropine Sulfate Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Atropine Sulfate Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Atropine Sulfate Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Atropine Sulfate Injection sales, projected growth trends, production technology, application and end-user industry.

Atropine Sulfate Injection Segment by Company

Tianjin Jinyao Pharmaceutical

Tai Yu Chemical & Pharmaceutical

Suicheng Pharmaceutical

CSPC Ouyi Pharmaceutical

China Shineway Pharm

Shanghai Harvest Pharmaceutical

Sunflower Pharmaceutical

Pfizer

China Res Double-Crane

Hubei Xinghua Pharmaceutical

Hebei Tiancheng Pharmaceutical

Hebei Kaiwei Pharmaceutical

Chengdu Brilliant Pharmaceutical

Changzhou Pharmaceutical Factory

Anhui Changjiang Pharmaceutical

Hikma Pharmaceuticals

Apotex

Amneal Pharmaceuticals

American Regent

Accord Healthcare

Atropine Sulfate Injection Segment by Type

0.5 mg/mL

1 mg/ml

5 mg/ml

Other

Atropine Sulfate Injection Segment by Application

Online Sales

Offline Sales

Atropine Sulfate Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Atropine Sulfate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Atropine Sulfate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Atropine Sulfate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Atropine Sulfate Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Atropine Sulfate Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Atropine Sulfate Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Atropine Sulfate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 0.5 mg/mL Major Manufacturers Table 3. 1 mg/ml Major Manufacturers Table 4. 5 mg/ml Major Manufacturers Table 5. Other Major Manufacturers Table 6. Global Atropine Sulfate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Online Sales Major Manufacturers Table 8. Offline Sales Major Manufacturers Table 9. Atropine Sulfate Injection Industry Trends Table 10. Atropine Sulfate Injection Industry Drivers Table 11. Atropine Sulfate Injection Industry Opportunities and Challenges Table 12. Atropine Sulfate Injection Industry Restraints Table 13. Global Atropine Sulfate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Atropine Sulfate Injection Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Atropine Sulfate Injection Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Atropine Sulfate Injection Revenue Market Share by Region (2021-2026) Table 17. Global Atropine Sulfate Injection Revenue Market Share by Region (2027-2032) Table 18. Global Atropine Sulfate Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 19. Global Atropine Sulfate Injection Sales by Region (2021-2026) & (k units) Table 20. Global Atropine Sulfate Injection Sales by Region (2027-2032) & (k units) Table 21. Global Atropine Sulfate Injection Sales Market Share by Region (2021-2026) Table 22. Global Atropine Sulfate Injection Sales Market Share by Region (2027-2032) Table 23. Global Atropine Sulfate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Atropine Sulfate Injection Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Atropine Sulfate Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Atropine Sulfate Injection Sales Market Share by Manufacturers (2021-2026) Table 27. Global Atropine Sulfate Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 28. Global Atropine Sulfate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Atropine Sulfate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Atropine Sulfate Injection Manufacturers, Product Type & Application Table 31. Global Atropine Sulfate Injection Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Atropine Sulfate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Atropine Sulfate Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Atropine Sulfate Injection Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Atropine Sulfate Injection Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Atropine Sulfate Injection Revenue Market Share by Type (2021-2026) Table 38. Global Atropine Sulfate Injection Revenue Market Share by Type (2027-2032) Table 39. Global Atropine Sulfate Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 40. Global Atropine Sulfate Injection Sales by Type (2021-2026) & (k units) Table 41. Global Atropine Sulfate Injection Sales by Type (2027-2032) & (k units) Table 42. Global Atropine Sulfate Injection Sales Market Share by Type (2021-2026) Table 43. Global Atropine Sulfate Injection Sales Market Share by Type (2027-2032) Table 44. Global Atropine Sulfate Injection Price by Type (2021-2026) & (US$/unit) Table 45. Global Atropine Sulfate Injection Price by Type (2027-2032) & (US$/unit) Table 46. Global Atropine Sulfate Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Atropine Sulfate Injection Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Atropine Sulfate Injection Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Atropine Sulfate Injection Revenue Market Share by Application (2021-2026) Table 50. Global Atropine Sulfate Injection Revenue Market Share by Application (2027-2032) Table 51. Global Atropine Sulfate Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 52. Global Atropine Sulfate Injection Sales by Application (2021-2026) & (k units) Table 53. Global Atropine Sulfate Injection Sales by Application (2027-2032) & (k units) Table 54. Global Atropine Sulfate Injection Sales Market Share by Application (2021-2026) Table 55. Global Atropine Sulfate Injection Sales Market Share by Application (2027-2032) Table 56. Global Atropine Sulfate Injection Price by Application (2021-2026) & (US$/unit) Table 57. Global Atropine Sulfate Injection Price by Application (2027-2032) & (US$/unit) Table 58. Tianjin Jinyao Pharmaceutical Company Information Table 59. Tianjin Jinyao Pharmaceutical Business Overview Table 60. Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 62. Tianjin Jinyao Pharmaceutical Recent Development Table 63. Tai Yu Chemical & Pharmaceutical Company Information Table 64. Tai Yu Chemical & Pharmaceutical Business Overview Table 65. Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 67. Tai Yu Chemical & Pharmaceutical Recent Development Table 68. Suicheng Pharmaceutical Company Information Table 69. Suicheng Pharmaceutical Business Overview Table 70. Suicheng Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Suicheng Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 72. Suicheng Pharmaceutical Recent Development Table 73. CSPC Ouyi Pharmaceutical Company Information Table 74. CSPC Ouyi Pharmaceutical Business Overview Table 75. CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 77. CSPC Ouyi Pharmaceutical Recent Development Table 78. China Shineway Pharm Company Information Table 79. China Shineway Pharm Business Overview Table 80. China Shineway Pharm Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. China Shineway Pharm Atropine Sulfate Injection Product Portfolio Table 82. China Shineway Pharm Recent Development Table 83. Shanghai Harvest Pharmaceutical Company Information Table 84. Shanghai Harvest Pharmaceutical Business Overview Table 85. Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 87. Shanghai Harvest Pharmaceutical Recent Development Table 88. Sunflower Pharmaceutical Company Information Table 89. Sunflower Pharmaceutical Business Overview Table 90. Sunflower Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Sunflower Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 92. Sunflower Pharmaceutical Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Pfizer Atropine Sulfate Injection Product Portfolio Table 97. Pfizer Recent Development Table 98. China Res Double-Crane Company Information Table 99. China Res Double-Crane Business Overview Table 100. China Res Double-Crane Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. China Res Double-Crane Atropine Sulfate Injection Product Portfolio Table 102. China Res Double-Crane Recent Development Table 103. Hubei Xinghua Pharmaceutical Company Information Table 104. Hubei Xinghua Pharmaceutical Business Overview Table 105. Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 107. Hubei Xinghua Pharmaceutical Recent Development Table 108. Hebei Tiancheng Pharmaceutical Company Information Table 109. Hebei Tiancheng Pharmaceutical Business Overview Table 110. Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 112. Hebei Tiancheng Pharmaceutical Recent Development Table 113. Hebei Kaiwei Pharmaceutical Company Information Table 114. Hebei Kaiwei Pharmaceutical Business Overview Table 115. Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 117. Hebei Kaiwei Pharmaceutical Recent Development Table 118. Chengdu Brilliant Pharmaceutical Company Information Table 119. Chengdu Brilliant Pharmaceutical Business Overview Table 120. Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 122. Chengdu Brilliant Pharmaceutical Recent Development Table 123. Changzhou Pharmaceutical Factory Company Information Table 124. Changzhou Pharmaceutical Factory Business Overview Table 125. Changzhou Pharmaceutical Factory Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Changzhou Pharmaceutical Factory Atropine Sulfate Injection Product Portfolio Table 127. Changzhou Pharmaceutical Factory Recent Development Table 128. Anhui Changjiang Pharmaceutical Company Information Table 129. Anhui Changjiang Pharmaceutical Business Overview Table 130. Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Product Portfolio Table 132. Anhui Changjiang Pharmaceutical Recent Development Table 133. Hikma Pharmaceuticals Company Information Table 134. Hikma Pharmaceuticals Business Overview Table 135. Hikma Pharmaceuticals Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Hikma Pharmaceuticals Atropine Sulfate Injection Product Portfolio Table 137. Hikma Pharmaceuticals Recent Development Table 138. Apotex Company Information Table 139. Apotex Business Overview Table 140. Apotex Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Apotex Atropine Sulfate Injection Product Portfolio Table 142. Apotex Recent Development Table 143. Amneal Pharmaceuticals Company Information Table 144. Amneal Pharmaceuticals Business Overview Table 145. Amneal Pharmaceuticals Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. Amneal Pharmaceuticals Atropine Sulfate Injection Product Portfolio Table 147. Amneal Pharmaceuticals Recent Development Table 148. American Regent Company Information Table 149. American Regent Business Overview Table 150. American Regent Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. American Regent Atropine Sulfate Injection Product Portfolio Table 152. American Regent Recent Development Table 153. Accord Healthcare Company Information Table 154. Accord Healthcare Business Overview Table 155. Accord Healthcare Atropine Sulfate Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. Accord Healthcare Atropine Sulfate Injection Product Portfolio Table 157. Accord Healthcare Recent Development Table 158. North America Atropine Sulfate Injection Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Atropine Sulfate Injection Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Atropine Sulfate Injection Sales by Type (2021-2026) & (k units) Table 161. North America Atropine Sulfate Injection Sales by Type (2027-2032) & (k units) Table 162. North America Atropine Sulfate Injection Sales Price by Type (2021-2026) & (US$/unit) Table 163. North America Atropine Sulfate Injection Sales Price by Type (2027-2032) & (US$/unit) Table 164. North America Atropine Sulfate Injection Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Atropine Sulfate Injection Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Atropine Sulfate Injection Sales by Application (2021-2026) & (k units) Table 167. North America Atropine Sulfate Injection Sales by Application (2027-2032) & (k units) Table 168. North America Atropine Sulfate Injection Sales Price by Application (2021-2026) & (US$/unit) Table 169. North America Atropine Sulfate Injection Sales Price by Application (2027-2032) & (US$/unit) Table 170. North America Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Atropine Sulfate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Atropine Sulfate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. North America Atropine Sulfate Injection Sales by Country (2021-2026) & (k units) Table 175. North America Atropine Sulfate Injection Sales by Country (2027-2032) & (k units) Table 176. North America Atropine Sulfate Injection Sales Price by Country (2021-2026) & (US$/unit) Table 177. North America Atropine Sulfate Injection Sales Price by Country (2027-2032) & (US$/unit) Table 178. United States Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 179. Canada Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 180. Mexico Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 181. Europe Atropine Sulfate Injection Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Atropine Sulfate Injection Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Atropine Sulfate Injection Sales by Type (2021-2026) & (k units) Table 184. Europe Atropine Sulfate Injection Sales by Type (2027-2032) & (k units) Table 185. Europe Atropine Sulfate Injection Sales Price by Type (2021-2026) & (US$/unit) Table 186. Europe Atropine Sulfate Injection Sales Price by Type (2027-2032) & (US$/unit) Table 187. Europe Atropine Sulfate Injection Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Atropine Sulfate Injection Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Atropine Sulfate Injection Sales by Application (2021-2026) & (k units) Table 190. Europe Atropine Sulfate Injection Sales by Application (2027-2032) & (k units) Table 191. Europe Atropine Sulfate Injection Sales Price by Application (2021-2026) & (US$/unit) Table 192. Europe Atropine Sulfate Injection Sales Price by Application (2027-2032) & (US$/unit) Table 193. Europe Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Atropine Sulfate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Atropine Sulfate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. Europe Atropine Sulfate Injection Sales by Country (2021-2026) & (k units) Table 198. Europe Atropine Sulfate Injection Sales by Country (2027-2032) & (k units) Table 199. Europe Atropine Sulfate Injection Sales Price by Country (2021-2026) & (US$/unit) Table 200. Europe Atropine Sulfate Injection Sales Price by Country (2027-2032) & (US$/unit) Table 201. Germany Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 202. France Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 203. U.K. Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 204. Italy Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 205. Russia Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 206. Spain Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 208. Switzerland Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 209. Sweden Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 210. Poland Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 211. China Atropine Sulfate Injection Revenue by Type (2021-2026) & (US$ Million) Table 212. China Atropine Sulfate Injection Revenue by Type (2027-2032) & (US$ Million) Table 213. China Atropine Sulfate Injection Sales by Type (2021-2026) & (k units) Table 214. China Atropine Sulfate Injection Sales by Type (2027-2032) & (k units) Table 215. China Atropine Sulfate Injection Sales Price by Type (2021-2026) & (US$/unit) Table 216. China Atropine Sulfate Injection Sales Price by Type (2027-2032) & (US$/unit) Table 217. China Atropine Sulfate Injection Revenue by Application (2021-2026) & (US$ Million) Table 218. China Atropine Sulfate Injection Revenue by Application (2027-2032) & (US$ Million) Table 219. China Atropine Sulfate Injection Sales by Application (2021-2026) & (k units) Table 220. China Atropine Sulfate Injection Sales by Application (2027-2032) & (k units) Table 221. China Atropine Sulfate Injection Sales Price by Application (2021-2026) & (US$/unit) Table 222. China Atropine Sulfate Injection Sales Price by Application (2027-2032) & (US$/unit) Table 223. Asia Atropine Sulfate Injection Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Atropine Sulfate Injection Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Atropine Sulfate Injection Sales by Type (2021-2026) & (k units) Table 226. Asia Atropine Sulfate Injection Sales by Type (2027-2032) & (k units) Table 227. Asia Atropine Sulfate Injection Sales Price by Type (2021-2026) & (US$/unit) Table 228. Asia Atropine Sulfate Injection Sales Price by Type (2027-2032) & (US$/unit) Table 229. Asia Atropine Sulfate Injection Revenue by Application (2021-2026) & (US$ Million) Table 230. Asia Atropine Sulfate Injection Revenue by Application (2027-2032) & (US$ Million) Table 231. Asia Atropine Sulfate Injection Sales by Application (2021-2026) & (k units) Table 232. Asia Atropine Sulfate Injection Sales by Application (2027-2032) & (k units) Table 233. Asia Atropine Sulfate Injection Sales Price by Application (2021-2026) & (US$/unit) Table 234. Asia Atropine Sulfate Injection Sales Price by Application (2027-2032) & (US$/unit) Table 235. Asia Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Atropine Sulfate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Atropine Sulfate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. Asia Atropine Sulfate Injection Sales by Country (2021-2026) & (k units) Table 240. Asia Atropine Sulfate Injection Sales by Country (2027-2032) & (k units) Table 241. Asia Atropine Sulfate Injection Sales Price by Country (2021-2026) & (US$/unit) Table 242. Asia Atropine Sulfate Injection Sales Price by Country (2027-2032) & (US$/unit) Table 243. Japan Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 244. South Korea Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 245. India Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 246. Australia Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 247. Taiwan Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Atropine Sulfate Injection Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Atropine Sulfate Injection Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Atropine Sulfate Injection Sales by Type (2021-2026) & (k units) Table 252. SAMEA Atropine Sulfate Injection Sales by Type (2027-2032) & (k units) Table 253. SAMEA Atropine Sulfate Injection Sales Price by Type (2021-2026) & (US$/unit) Table 254. SAMEA Atropine Sulfate Injection Sales Price by Type (2027-2032) & (US$/unit) Table 255. SAMEA Atropine Sulfate Injection Revenue by Application (2021-2026) & (US$ Million) Table 256. SAMEA Atropine Sulfate Injection Revenue by Application (2027-2032) & (US$ Million) Table 257. SAMEA Atropine Sulfate Injection Sales by Application (2021-2026) & (k units) Table 258. SAMEA Atropine Sulfate Injection Sales by Application (2027-2032) & (k units) Table 259. SAMEA Atropine Sulfate Injection Sales Price by Application (2021-2026) & (US$/unit) Table 260. SAMEA Atropine Sulfate Injection Sales Price by Application (2027-2032) & (US$/unit) Table 261. SAMEA Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Atropine Sulfate Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Atropine Sulfate Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 265. SAMEA Atropine Sulfate Injection Sales by Country (2021-2026) & (k units) Table 266. SAMEA Atropine Sulfate Injection Sales by Country (2027-2032) & (k units) Table 267. SAMEA Atropine Sulfate Injection Sales Price by Country (2021-2026) & (US$/unit) Table 268. SAMEA Atropine Sulfate Injection Sales Price by Country (2027-2032) & (US$/unit) Table 269. Brazil Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 270. Argentina Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 271. Chile Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 272. Colombia Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 273. Peru Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 275. Israel Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 276. UAE Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 277. Turkey Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 278. Iran Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 279. Egypt Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Atropine Sulfate Injection Distributors List Table 283. Atropine Sulfate Injection Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Atropine Sulfate Injection Image Figure 2. Global Atropine Sulfate Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Atropine Sulfate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 0.5 mg/mL Image Figure 5. 1 mg/ml Image Figure 6. 5 mg/ml Image Figure 7. Other Image Figure 8. Global Atropine Sulfate Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Atropine Sulfate Injection Market Size Share 2021 VS 2025 VS 2032 Figure 10. Online Sales Image Figure 11. Offline Sales Image Figure 12. Global Atropine Sulfate Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Atropine Sulfate Injection Revenue (2021-2032) & (US$ Million) Figure 14. Global Atropine Sulfate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Atropine Sulfate Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Atropine Sulfate Injection Revenue Market Share by Region (2021-2032) Figure 17. Global Atropine Sulfate Injection Sales (2021-2032) & (k units) Figure 18. Global Atropine Sulfate Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 19. Global Atropine Sulfate Injection Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Atropine Sulfate Injection Sales YoY (2021-2032) & (k units) Figure 21. Europe Atropine Sulfate Injection Sales YoY (2021-2032) & (k units) Figure 22. China Atropine Sulfate Injection Sales YoY (2021-2032) & (k units) Figure 23. Asia (Excluding China) Atropine Sulfate Injection Sales YoY (2021-2032) & (k units) Figure 24. South America, Middle East and Africa Atropine Sulfate Injection Sales YoY (2021-2032) & (k units) Figure 25. Global Atropine Sulfate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Atropine Sulfate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Atropine Sulfate Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Atropine Sulfate Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Atropine Sulfate Injection Revenue Market Share by Type (2021-2032) Figure 31. Global Atropine Sulfate Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 32. Global Atropine Sulfate Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Atropine Sulfate Injection Sales Market Share by Type (2021-2032) Figure 34. Global Atropine Sulfate Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Atropine Sulfate Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Atropine Sulfate Injection Revenue Market Share by Application (2021-2032) Figure 37. Global Atropine Sulfate Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 38. Global Atropine Sulfate Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Atropine Sulfate Injection Sales Market Share by Application (2021-2032) Figure 40. North America Atropine Sulfate Injection Revenue Share by Type (2021-2032) Figure 41. North America Atropine Sulfate Injection Sales Share by Type (2021-2032) Figure 42. North America Atropine Sulfate Injection Revenue Share by Application (2021-2032) Figure 43. North America Atropine Sulfate Injection Sales Share by Application (2021-2032) Figure 44. North America Atropine Sulfate Injection Revenue Share by Country (2021-2032) Figure 45. North America Atropine Sulfate Injection Sales Share by Country (2021-2032) Figure 46. Europe Atropine Sulfate Injection Revenue Share by Type (2021-2032) Figure 47. Europe Atropine Sulfate Injection Sales Share by Type (2021-2032) Figure 48. Europe Atropine Sulfate Injection Revenue Share by Application (2021-2032) Figure 49. Europe Atropine Sulfate Injection Sales Share by Application (2021-2032) Figure 50. Europe Atropine Sulfate Injection Revenue Share by Country (2021-2032) Figure 51. Europe Atropine Sulfate Injection Sales Share by Country (2021-2032) Figure 52. China Atropine Sulfate Injection Revenue Share by Type (2021-2032) Figure 53. China Atropine Sulfate Injection Sales Share by Type (2021-2032) Figure 54. China Atropine Sulfate Injection Revenue Share by Application (2021-2032) Figure 55. China Atropine Sulfate Injection Sales Share by Application (2021-2032) Figure 56. Asia Atropine Sulfate Injection Revenue Share by Type (2021-2032) Figure 57. Asia Atropine Sulfate Injection Sales Share by Type (2021-2032) Figure 58. Asia Atropine Sulfate Injection Revenue Share by Application (2021-2032) Figure 59. Asia Atropine Sulfate Injection Sales Share by Application (2021-2032) Figure 60. Asia Atropine Sulfate Injection Revenue Share by Country (2021-2032) Figure 61. Asia Atropine Sulfate Injection Sales Share by Country (2021-2032) Figure 62. SAMEA Atropine Sulfate Injection Revenue Share by Type (2021-2032) Figure 63. SAMEA Atropine Sulfate Injection Sales Share by Type (2021-2032) Figure 64. SAMEA Atropine Sulfate Injection Revenue Share by Application (2021-2032) Figure 65. SAMEA Atropine Sulfate Injection Sales Share by Application (2021-2032) Figure 66. SAMEA Atropine Sulfate Injection Revenue Share by Country (2021-2032) Figure 67. SAMEA Atropine Sulfate Injection Sales Share by Country (2021-2032) Figure 68. Atropine Sulfate Injection Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Atropine Sulfate Injection Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 0.5 mg/mL
  • 1 mg/ml
  • 5 mg/ml
  • Other
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Tianjin Jinyao Pharmaceutical
  • Tai Yu Chemical & Pharmaceutical
  • Suicheng Pharmaceutical
  • CSPC Ouyi Pharmaceutical
  • China Shineway Pharm
  • Shanghai Harvest Pharmaceutical
  • Sunflower Pharmaceutical
  • Pfizer
  • China Res Double-Crane
  • Hubei Xinghua Pharmaceutical
  • Hebei Tiancheng Pharmaceutical
  • Hebei Kaiwei Pharmaceutical
  • Chengdu Brilliant Pharmaceutical
  • Changzhou Pharmaceutical Factory
  • Anhui Changjiang Pharmaceutical
  • Hikma Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • American Regent
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Atropine Sulfate Injection Market by Type
  3. 1.2.1 Global Atropine Sulfate Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 0.5 mg/mL
  5. 1.2.3 1 mg/ml
  6. 1.2.4 5 mg/ml
  7. 1.2.5 Other
  8. 1.3 Atropine Sulfate Injection Market by Application
  9. 1.3.1 Global Atropine Sulfate Injection Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Online Sales
  11. 1.3.3 Offline Sales
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Atropine Sulfate Injection Market Dynamics
  1. 2.1 Atropine Sulfate Injection Industry Trends
  2. 2.2 Atropine Sulfate Injection Industry Drivers
  3. 2.3 Atropine Sulfate Injection Industry Opportunities and Challenges
  4. 2.4 Atropine Sulfate Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Atropine Sulfate Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Atropine Sulfate Injection Revenue by Region
  3. 3.2.1 Global Atropine Sulfate Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Atropine Sulfate Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Atropine Sulfate Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Atropine Sulfate Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Atropine Sulfate Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Atropine Sulfate Injection Sales by Region
  9. 3.4.1 Global Atropine Sulfate Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Atropine Sulfate Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Atropine Sulfate Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Atropine Sulfate Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Atropine Sulfate Injection Revenue by Manufacturers
  2. 4.1.1 Global Atropine Sulfate Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Atropine Sulfate Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Atropine Sulfate Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Atropine Sulfate Injection Sales by Manufacturers
  6. 4.2.1 Global Atropine Sulfate Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Atropine Sulfate Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Atropine Sulfate Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Atropine Sulfate Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Atropine Sulfate Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Atropine Sulfate Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Atropine Sulfate Injection Manufacturers, Product Type & Application
  13. 4.7 Global Atropine Sulfate Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Atropine Sulfate Injection Market CR5 and HHI
  16. 4.8.2 2025 Atropine Sulfate Injection Tier 1, Tier 2, and Tier 3
5 Atropine Sulfate Injection Market by Type
  1. 5.1 Global Atropine Sulfate Injection Revenue by Type
  2. 5.1.1 Global Atropine Sulfate Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Atropine Sulfate Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Atropine Sulfate Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Atropine Sulfate Injection Sales by Type
  6. 5.2.1 Global Atropine Sulfate Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Atropine Sulfate Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Atropine Sulfate Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Atropine Sulfate Injection Price by Type
6 Atropine Sulfate Injection Market by Application
  1. 6.1 Global Atropine Sulfate Injection Revenue by Application
  2. 6.1.1 Global Atropine Sulfate Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Atropine Sulfate Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Atropine Sulfate Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Atropine Sulfate Injection Sales by Application
  6. 6.2.1 Global Atropine Sulfate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Atropine Sulfate Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Atropine Sulfate Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Atropine Sulfate Injection Price by Application
7 Company Profiles
  1. 7.1 Tianjin Jinyao Pharmaceutical
  2. 7.1.1 Tianjin Jinyao Pharmaceutical Company Information
  3. 7.1.2 Tianjin Jinyao Pharmaceutical Business Overview
  4. 7.1.3 Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Tianjin Jinyao Pharmaceutical Atropine Sulfate Injection Product Portfolio
  6. 7.1.5 Tianjin Jinyao Pharmaceutical Recent Developments
  7. 7.2 Tai Yu Chemical & Pharmaceutical
  8. 7.2.1 Tai Yu Chemical & Pharmaceutical Company Information
  9. 7.2.2 Tai Yu Chemical & Pharmaceutical Business Overview
  10. 7.2.3 Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Tai Yu Chemical & Pharmaceutical Atropine Sulfate Injection Product Portfolio
  12. 7.2.5 Tai Yu Chemical & Pharmaceutical Recent Developments
  13. 7.3 Suicheng Pharmaceutical
  14. 7.3.1 Suicheng Pharmaceutical Company Information
  15. 7.3.2 Suicheng Pharmaceutical Business Overview
  16. 7.3.3 Suicheng Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Suicheng Pharmaceutical Atropine Sulfate Injection Product Portfolio
  18. 7.3.5 Suicheng Pharmaceutical Recent Developments
  19. 7.4 CSPC Ouyi Pharmaceutical
  20. 7.4.1 CSPC Ouyi Pharmaceutical Company Information
  21. 7.4.2 CSPC Ouyi Pharmaceutical Business Overview
  22. 7.4.3 CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 CSPC Ouyi Pharmaceutical Atropine Sulfate Injection Product Portfolio
  24. 7.4.5 CSPC Ouyi Pharmaceutical Recent Developments
  25. 7.5 China Shineway Pharm
  26. 7.5.1 China Shineway Pharm Company Information
  27. 7.5.2 China Shineway Pharm Business Overview
  28. 7.5.3 China Shineway Pharm Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 China Shineway Pharm Atropine Sulfate Injection Product Portfolio
  30. 7.5.5 China Shineway Pharm Recent Developments
  31. 7.6 Shanghai Harvest Pharmaceutical
  32. 7.6.1 Shanghai Harvest Pharmaceutical Company Information
  33. 7.6.2 Shanghai Harvest Pharmaceutical Business Overview
  34. 7.6.3 Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Shanghai Harvest Pharmaceutical Atropine Sulfate Injection Product Portfolio
  36. 7.6.5 Shanghai Harvest Pharmaceutical Recent Developments
  37. 7.7 Sunflower Pharmaceutical
  38. 7.7.1 Sunflower Pharmaceutical Company Information
  39. 7.7.2 Sunflower Pharmaceutical Business Overview
  40. 7.7.3 Sunflower Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sunflower Pharmaceutical Atropine Sulfate Injection Product Portfolio
  42. 7.7.5 Sunflower Pharmaceutical Recent Developments
  43. 7.8 Pfizer
  44. 7.8.1 Pfizer Company Information
  45. 7.8.2 Pfizer Business Overview
  46. 7.8.3 Pfizer Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Pfizer Atropine Sulfate Injection Product Portfolio
  48. 7.8.5 Pfizer Recent Developments
  49. 7.9 China Res Double-Crane
  50. 7.9.1 China Res Double-Crane Company Information
  51. 7.9.2 China Res Double-Crane Business Overview
  52. 7.9.3 China Res Double-Crane Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 China Res Double-Crane Atropine Sulfate Injection Product Portfolio
  54. 7.9.5 China Res Double-Crane Recent Developments
  55. 7.10 Hubei Xinghua Pharmaceutical
  56. 7.10.1 Hubei Xinghua Pharmaceutical Company Information
  57. 7.10.2 Hubei Xinghua Pharmaceutical Business Overview
  58. 7.10.3 Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Hubei Xinghua Pharmaceutical Atropine Sulfate Injection Product Portfolio
  60. 7.10.5 Hubei Xinghua Pharmaceutical Recent Developments
  61. 7.11 Hebei Tiancheng Pharmaceutical
  62. 7.11.1 Hebei Tiancheng Pharmaceutical Company Information
  63. 7.11.2 Hebei Tiancheng Pharmaceutical Business Overview
  64. 7.11.3 Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Hebei Tiancheng Pharmaceutical Atropine Sulfate Injection Product Portfolio
  66. 7.11.5 Hebei Tiancheng Pharmaceutical Recent Developments
  67. 7.12 Hebei Kaiwei Pharmaceutical
  68. 7.12.1 Hebei Kaiwei Pharmaceutical Company Information
  69. 7.12.2 Hebei Kaiwei Pharmaceutical Business Overview
  70. 7.12.3 Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Hebei Kaiwei Pharmaceutical Atropine Sulfate Injection Product Portfolio
  72. 7.12.5 Hebei Kaiwei Pharmaceutical Recent Developments
  73. 7.13 Chengdu Brilliant Pharmaceutical
  74. 7.13.1 Chengdu Brilliant Pharmaceutical Company Information
  75. 7.13.2 Chengdu Brilliant Pharmaceutical Business Overview
  76. 7.13.3 Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Chengdu Brilliant Pharmaceutical Atropine Sulfate Injection Product Portfolio
  78. 7.13.5 Chengdu Brilliant Pharmaceutical Recent Developments
  79. 7.14 Changzhou Pharmaceutical Factory
  80. 7.14.1 Changzhou Pharmaceutical Factory Company Information
  81. 7.14.2 Changzhou Pharmaceutical Factory Business Overview
  82. 7.14.3 Changzhou Pharmaceutical Factory Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Changzhou Pharmaceutical Factory Atropine Sulfate Injection Product Portfolio
  84. 7.14.5 Changzhou Pharmaceutical Factory Recent Developments
  85. 7.15 Anhui Changjiang Pharmaceutical
  86. 7.15.1 Anhui Changjiang Pharmaceutical Company Information
  87. 7.15.2 Anhui Changjiang Pharmaceutical Business Overview
  88. 7.15.3 Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Anhui Changjiang Pharmaceutical Atropine Sulfate Injection Product Portfolio
  90. 7.15.5 Anhui Changjiang Pharmaceutical Recent Developments
  91. 7.16 Hikma Pharmaceuticals
  92. 7.16.1 Hikma Pharmaceuticals Company Information
  93. 7.16.2 Hikma Pharmaceuticals Business Overview
  94. 7.16.3 Hikma Pharmaceuticals Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Hikma Pharmaceuticals Atropine Sulfate Injection Product Portfolio
  96. 7.16.5 Hikma Pharmaceuticals Recent Developments
  97. 7.17 Apotex
  98. 7.17.1 Apotex Company Information
  99. 7.17.2 Apotex Business Overview
  100. 7.17.3 Apotex Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Apotex Atropine Sulfate Injection Product Portfolio
  102. 7.17.5 Apotex Recent Developments
  103. 7.18 Amneal Pharmaceuticals
  104. 7.18.1 Amneal Pharmaceuticals Company Information
  105. 7.18.2 Amneal Pharmaceuticals Business Overview
  106. 7.18.3 Amneal Pharmaceuticals Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Amneal Pharmaceuticals Atropine Sulfate Injection Product Portfolio
  108. 7.18.5 Amneal Pharmaceuticals Recent Developments
  109. 7.19 American Regent
  110. 7.19.1 American Regent Company Information
  111. 7.19.2 American Regent Business Overview
  112. 7.19.3 American Regent Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 American Regent Atropine Sulfate Injection Product Portfolio
  114. 7.19.5 American Regent Recent Developments
  115. 7.20 Accord Healthcare
  116. 7.20.1 Accord Healthcare Company Information
  117. 7.20.2 Accord Healthcare Business Overview
  118. 7.20.3 Accord Healthcare Atropine Sulfate Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  119. 7.20.4 Accord Healthcare Atropine Sulfate Injection Product Portfolio
  120. 7.20.5 Accord Healthcare Recent Developments
8 North America
  1. 8.1 North America Atropine Sulfate Injection Market Size by Type
  2. 8.1.1 North America Atropine Sulfate Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Atropine Sulfate Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Atropine Sulfate Injection Price by Type (2021-2032)
  5. 8.2 North America Atropine Sulfate Injection Market Size by Application
  6. 8.2.1 North America Atropine Sulfate Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Atropine Sulfate Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Atropine Sulfate Injection Price by Application (2021-2032)
  9. 8.3 North America Atropine Sulfate Injection Market Size by Country
  10. 8.3.1 North America Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Atropine Sulfate Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Atropine Sulfate Injection Market Size by Type
  2. 9.1.1 Europe Atropine Sulfate Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Atropine Sulfate Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Atropine Sulfate Injection Price by Type (2021-2032)
  5. 9.2 Europe Atropine Sulfate Injection Market Size by Application
  6. 9.2.1 Europe Atropine Sulfate Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Atropine Sulfate Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Atropine Sulfate Injection Price by Application (2021-2032)
  9. 9.3 Europe Atropine Sulfate Injection Market Size by Country
  10. 9.3.1 Europe Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Atropine Sulfate Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Atropine Sulfate Injection Market Size by Type
  2. 10.1.1 China Atropine Sulfate Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Atropine Sulfate Injection Sales by Type (2021-2032)
  4. 10.1.3 China Atropine Sulfate Injection Price by Type (2021-2032)
  5. 10.2 China Atropine Sulfate Injection Market Size by Application
  6. 10.2.1 China Atropine Sulfate Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Atropine Sulfate Injection Sales by Application (2021-2032)
  8. 10.2.3 China Atropine Sulfate Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Atropine Sulfate Injection Market Size by Type
  2. 11.1.1 Asia Atropine Sulfate Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Atropine Sulfate Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Atropine Sulfate Injection Price by Type (2021-2032)
  5. 11.2 Asia Atropine Sulfate Injection Market Size by Application
  6. 11.2.1 Asia Atropine Sulfate Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Atropine Sulfate Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Atropine Sulfate Injection Price by Application (2021-2032)
  9. 11.3 Asia Atropine Sulfate Injection Market Size by Country
  10. 11.3.1 Asia Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Atropine Sulfate Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Atropine Sulfate Injection Market Size by Type
  2. 12.1.1 SAMEA Atropine Sulfate Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Atropine Sulfate Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Atropine Sulfate Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Atropine Sulfate Injection Market Size by Application
  6. 12.2.1 SAMEA Atropine Sulfate Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Atropine Sulfate Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Atropine Sulfate Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Atropine Sulfate Injection Market Size by Country
  10. 12.3.1 SAMEA Atropine Sulfate Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Atropine Sulfate Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Atropine Sulfate Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Atropine Sulfate Injection Value Chain Analysis
  2. 13.1.1 Atropine Sulfate Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Atropine Sulfate Injection Production Mode & Process
  6. 13.2 Atropine Sulfate Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Atropine Sulfate Injection Distributors
  9. 13.2.3 Atropine Sulfate Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst